{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:47:11Z","timestamp":1790192831544,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.thromres.2021.04.012","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T10:30:39Z","timestamp":1618914639000},"page":"191-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["COVID-19 and thrombotic microangiopathies"],"prefix":"10.1016","volume":"202","author":[{"given":"Nishant R.","family":"Tiwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanat","family":"Phatak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek R.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K.","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2021.04.012_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2021.04.012_bb0015","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"issue":"11","key":"10.1016\/j.thromres.2021.04.012_bb0020","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA - J Am Med Assoc."},{"issue":"5","key":"10.1016\/j.thromres.2021.04.012_bb0025","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41422-020-0327-4","article-title":"COVID-19: towards understanding of pathogenesis","volume":"30","author":"Cao","year":"2020","journal-title":"Cell Res."},{"issue":"17","key":"10.1016\/j.thromres.2021.04.012_bb0030","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with covid-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.thromres.2021.04.012_bb0035","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2020-323586","article-title":"Characteristics of ischaemic stroke associated with COVID-19","volume":"91","author":"Beyrouti","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9","key":"10.1016\/j.thromres.2021.04.012_bb0040","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1007\/s10067-020-05275-1","article-title":"Thrombosis in coronavirus disease 2019 (COVID-19) through the prism of Virchow\u2019s triad","volume":"39","author":"Ahmed","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.thromres.2021.04.012_bb0045","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620936776","article-title":"Viral coagulopathy in patients with COVID-19: treatment and care","volume":"26","author":"Kipshidze","year":"2020","journal-title":"Clin. Appl. Thromb."},{"issue":"7","key":"10.1016\/j.thromres.2021.04.012_bb0050","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.thromres.2021.04.012_bb0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5144\/1658-3876.2011.51","article-title":"Viral-associated thrombotic microangiopathies","volume":"4","author":"da Silva","year":"2011","journal-title":"Hematol. Oncol. Stem. Cell Ther."},{"key":"10.1016\/j.thromres.2021.04.012_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(20)30434-5","article-title":"Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study","author":"Carsana","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.thromres.2021.04.012_bb0065","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.thromres.2021.04.012_bb0070","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1086\/314829","article-title":"Review: infectious diseases and coagulation disorders","volume":"180","author":"van Gorp","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"April","key":"10.1016\/j.thromres.2021.04.012_bb0075","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","article-title":"Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2021.04.012_bb0080","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.16908","article-title":"Prevalence of venous thromboembolism in critically ill patients with COVID-19","volume":"190","author":"Hippensteel","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.thromres.2021.04.012_bb0085","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.10478","article-title":"Venous thrombosis among critically ill patients with coronavirus disease 2019 (COVID-19)","volume":"3","author":"Nahum","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.thromres.2021.04.012_bb0090","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJMc2013656","article-title":"Lupus anticoagulant and abnormal coagulation tests in patients with Covid-19","volume":"383","author":"Bowles","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.thromres.2021.04.012_bb0095","doi-asserted-by":"crossref","DOI":"10.1111\/jth.14867","article-title":"Lupus anticoagulant is frequent in patients with Covid-19","volume":"18","author":"Harzallah","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2021.04.012_bb0100","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med."},{"issue":"3\u20134","key":"10.1016\/j.thromres.2021.04.012_bb0105","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jaut.2009.02.008","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the \u201cCAPS Registry.\u201d","volume":"32","author":"Cervera","year":"2009","journal-title":"J. Autoimmun."},{"issue":"17","key":"10.1016\/j.thromres.2021.04.012_bb0110","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.thromres.2021.04.012_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/toxins12020067","article-title":"Shiga toxin-associated hemolytic uremic syndrome: a narrative review","volume":"12","author":"Joseph","year":"2020","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.thromres.2021.04.012_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl. Res."},{"issue":"2","key":"10.1016\/j.thromres.2021.04.012_bb0125","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.kint.2020.05.013","article-title":"The case of complement activation in COVID-19 multiorgan impact","volume":"98","author":"Noris","year":"2020","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.thromres.2021.04.012_bb0130","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00296-020-04768-1","article-title":"Proposal of a new nomenclature for the underlying pathogenetic mechanism of severe Coronavirus Disease-19: \u201cInflammatory Thrombosis with Immune Endotheliitis\u2014ITIE.\u201d","volume":"41","author":"Bilgin","year":"2021","journal-title":"Rheumatol. Int."},{"issue":"4","key":"10.1016\/j.thromres.2021.04.012_bb0135","doi-asserted-by":"crossref","DOI":"10.1177\/2045894020966547","article-title":"Circulating markers of angiogenesis and endotheliopathy in COVID-19","volume":"10","author":"Pine","year":"2020","journal-title":"Pulm. Circ."},{"issue":"7","key":"10.1016\/j.thromres.2021.04.012_bb0140","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","article-title":"COVID-19: the vasculature unleashed","volume":"20","author":"Teuwen","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.thromres.2021.04.012_bb0145","doi-asserted-by":"crossref","unstructured":"Mohamed MM, Lukitsch I, Torres-Ortiz AE, et al. Acute kidney injury associated with coronavirus disease 2019 in Urban New Orleans. Kidney 360. 2020;1(7):10.34067\/KID.0002652020. doi:10.34067\/kid.0002652020.","DOI":"10.34067\/KID.0002652020"},{"key":"10.1016\/j.thromres.2021.04.012_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2020.04.003","article-title":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China","author":"Su","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.thromres.2021.04.012_bb0155","series-title":"Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series From New Orleans. medRxiv","author":"Fox","year":"2020"},{"issue":"7","key":"10.1016\/j.thromres.2021.04.012_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30243-5","article-title":"Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans","volume":"8","author":"Fox","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.thromres.2021.04.012_bb0165","first-page":"24","article-title":"Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: a case series","author":"Rapkiewicz","year":"2020","journal-title":"EClinicalMedicine."},{"key":"10.1016\/j.thromres.2021.04.012_bb0170","doi-asserted-by":"crossref","DOI":"10.1111\/his.14134","article-title":"Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction","author":"Menter","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.thromres.2021.04.012_bb0175","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.kint.2020.05.025","article-title":"Suyin Flores Chang B, et al. thrombotic microangiopathy in a patient with COVID-19","volume":"98","author":"Jhaveri","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.thromres.2021.04.012_bb0180","article-title":"COVID-19\u2013associated kidney injury: a case series of kidney biopsy findings","author":"Sharma","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.thromres.2021.04.012_bb0185","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/bcp.13808","article-title":"Thrombotic microangiopathy associated with gemcitabine use: presentation and outcome in a national French retrospective cohort","volume":"85","author":"Daviet","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.thromres.2021.04.012_bb0190","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s00277-020-04097-0","article-title":"Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19","volume":"99","author":"Albiol","year":"2020","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.thromres.2021.04.012_bb0195","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.thromres.2020.07.005","article-title":"Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: report of a case","volume":"195","author":"Hindilerden","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2021.04.012_bb0200","article-title":"Dramatic presentation of acquired TTP associated with COVID-19","author":"Capecchi","year":"2020","journal-title":"Haematologica"},{"issue":"10234","key":"10.1016\/j.thromres.2021.04.012_bb0205","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet."},{"issue":"8","key":"10.1016\/j.thromres.2021.04.012_bb0210","doi-asserted-by":"crossref","DOI":"10.3174\/ajnr.A6630","article-title":"Neuroimaging findings in patients with COVID-19","volume":"41","author":"Nicholson","year":"2020","journal-title":"Am. J. Neuroradiol."},{"issue":"1","key":"10.1016\/j.thromres.2021.04.012_bb0215","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.ajkd.2018.11.012","article-title":"An ex vivo test of complement activation on endothelium for individualized eculizumab therapy in hemolytic uremic syndrome","volume":"74","author":"Galbusera","year":"2019","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"10.1016\/j.thromres.2021.04.012_bb0220","first-page":"530","article-title":"Clinical and laboratory diagnosis of TTP: an integrated approach","volume":"2018","author":"Chiasakul","year":"2018","journal-title":"Hematol (United States)."},{"key":"10.1016\/j.thromres.2021.04.012_bb0225","article-title":"Dexamethasone in hospitalized patients with Covid-19 - preliminary report","author":"Horby","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.thromres.2021.04.012_bb0230","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2215\/CJN.00620117","article-title":"Thrombotic microangiopathy and the kidney","volume":"13","author":"Brocklebank","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"23","key":"10.1016\/j.thromres.2021.04.012_bb0235","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.thromres.2021.04.012_bb0240","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/annrheumdis-2018-214559","article-title":"Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: a multicentre cohort study","volume":"78","author":"Sciascia","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.thromres.2021.04.012_bb0245","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.mayocp.2016.05.015","article-title":"Thrombotic Microangiopathy care pathway: a consensus statement for the Mayo Clinic complement alternative pathway-thrombotic Microangiopathy (CAP-TMA) disease-oriented group","volume":"91","author":"Go","year":"2016","journal-title":"Mayo Clin. Proc."},{"issue":"7","key":"10.1016\/j.thromres.2021.04.012_bb0250","doi-asserted-by":"crossref","DOI":"10.1007\/s11886-020-01328-8","article-title":"The role of anticoagulation in COVID-19-induced hypercoagulability","volume":"22","author":"Rico-Mesa","year":"2020","journal-title":"Curr. Cardiol. Rep."},{"issue":"6","key":"10.1016\/j.thromres.2021.04.012_bb0255","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1056\/NEJM199108083250605","article-title":"Improved survival in thrombotic thrombocytopenic purpura\u2013hemolytic uremic syndrome: clinical experience in 108 patients","volume":"325","author":"Bell","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.thromres.2021.04.012_bb0260","first-page":"539","article-title":"Beyond plasma exchange: novel therapies for thrombotic thrombocytopenic purpura","volume":"2018","author":"Dane","year":"2018","journal-title":"Hematol (United States)."},{"issue":"DEC","key":"10.1016\/j.thromres.2021.04.012_bb0265","article-title":"Endothelial response to glucocorticoids in inflammatory diseases","volume":"7","author":"Zieli\u0144ska","year":"2016","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.thromres.2021.04.012_bb0270","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1128\/iai.38.1.122-126.1982","article-title":"Methylprednisolone inhibits the alternative and amplification pathways of complement","volume":"38","author":"Weiler","year":"1982","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.thromres.2021.04.012_bb0275","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1172\/JCI0215481","article-title":"Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids","volume":"110","author":"Limbourg","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.thromres.2021.04.012_bb0280","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med."},{"issue":"15","key":"10.1016\/j.thromres.2021.04.012_bb0285","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.thromres.2021.04.012_bb0290","series-title":"GLUCOCOVID: A Controlled Trial of Methylprednisolone in Adults Hospitalized With COVID-19 Pneumonia. medRxiv","author":"Corral","year":"2020"},{"issue":"6","key":"10.1016\/j.thromres.2021.04.012_bb0295","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00277-009-0877-5","article-title":"High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study","volume":"89","author":"Balduini","year":"2010","journal-title":"Ann. Hematol."},{"issue":"21","key":"10.1016\/j.thromres.2021.04.012_bb0300","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly","year":"2017","journal-title":"Blood."},{"issue":"19","key":"10.1016\/j.thromres.2021.04.012_bb0305","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.thromres.2021.04.012_bb0310","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1348-0421.2011.00309.x","article-title":"Serum concentrations of complement anaphylatoxins and proinflammatory mediators in patients with 2009 H1N1 influenza","volume":"55","author":"Ohta","year":"2011","journal-title":"Microbiol. Immunol."},{"issue":"1","key":"10.1016\/j.thromres.2021.04.012_bb0315","doi-asserted-by":"crossref","DOI":"10.1038\/s41426-018-0063-8","article-title":"Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV article","volume":"7","author":"Jiang","year":"2018","journal-title":"Emerg. Microbes. Infect."},{"issue":"3","key":"10.1016\/j.thromres.2021.04.012_bb0320","article-title":"A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza a virus infection","volume":"6","author":"O\u2019Brien","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.thromres.2021.04.012_bb0325","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1165\/rcmb.2012-0428OC","article-title":"Inhibition of complement activation alleviates acute lung injury induced by highly pathogenic avian influenza H5N1 virus infection","volume":"49","author":"Sun","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"5","key":"10.1016\/j.thromres.2021.04.012_bb0330","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01753-18","article-title":"Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis","volume":"9","author":"Gralinski","year":"2018","journal-title":"MBio"},{"issue":"2","key":"10.1016\/j.thromres.2021.04.012_bb0335","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.virol.2010.12.045","article-title":"Complement and viral pathogenesis","volume":"411","author":"Stoermer","year":"2011","journal-title":"Virology."},{"issue":"7","key":"10.1016\/j.thromres.2021.04.012_bb0340","first-page":"4040","article-title":"Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience","volume":"24","author":"Diurno","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.thromres.2021.04.012_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108450","article-title":"The first case of COVID-19 treated with the complement C3 inhibitor AMY-101","volume":"215","author":"Mastaglio","year":"2020","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.thromres.2021.04.012_bb0355","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1182\/asheducation-2017.1.632","article-title":"Plasma exchange in thrombotic microangiopathies (TMAs) other than thrombotic thrombocytopenic purpura (TTP)","volume":"2017","author":"Winters","year":"2017","journal-title":"Hematology."},{"issue":"6","key":"10.1016\/j.thromres.2021.04.012_bb0360","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura","volume":"325","author":"Rock","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2021.04.012_bb0365","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijid.2020.06.064","article-title":"Therapeutic plasma exchange in adults with severe COVID-19 infection","volume":"99","author":"Khamis","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.thromres.2021.04.012_bb0370","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/s13054-020-03215-8","article-title":"Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study","volume":"24","author":"Gucyetmez","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.thromres.2021.04.012_bb0375","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25961","article-title":"Convalescent plasma transfusion for the treatment of COVID-19: systematic review","author":"Rajendran","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.thromres.2021.04.012_bb0380","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.10218","article-title":"A randomized trial of convalescent plasma for COVID-19 - potentially hopeful signals","author":"Casadevall","year":"2020","journal-title":"JAMA - J Am Med Assoc."},{"issue":"7","key":"10.1016\/j.thromres.2021.04.012_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102554","article-title":"Convalescent plasma in Covid-19: possible mechanisms of action","volume":"19","author":"Rojas","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.thromres.2021.04.012_bb0390","article-title":"Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia","author":"Guilpain","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.thromres.2021.04.012_bb0395","author":"COVID-19 and TTP - Hematology.org"},{"issue":"17","key":"10.1016\/j.thromres.2021.04.012_bb0400","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1182\/blood-2012-04-420943","article-title":"Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura","volume":"120","author":"Callewaert","year":"2012","journal-title":"Blood."},{"issue":"4","key":"10.1016\/j.thromres.2021.04.012_bb0405","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa1806311","article-title":"Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura","volume":"380","author":"Scully","year":"2019","journal-title":"N. Engl. J. Med."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384821002978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384821002978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:46:43Z","timestamp":1758736003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384821002978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":79,"alternative-id":["S0049384821002978"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2021.04.012","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 and thrombotic microangiopathies","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2021.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}